報價延遲最少15分鐘:2026/05/20 20:29 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.72 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.58/-0.13
|
|
企業價值
101.41M
|
| 資產負債 |
|
每股賬面淨值
1.02
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
34.51M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and salesof science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions. |
